Am Front Line Doctors sue US gov. over covid
Dept. of Human Services
afld-dhhs-documents/injunction-index.pdf
Doc-10-Original-AFLDrs-Complaint-1.pdf
afld-dhhs-documents/Motion-for-Preliminary-Injunction-file-stamped.pdf
According to a press release, America’s Frontline Doctors (AFLDS) is asking in a motion filed July 19, 2021 to immediately stop administration of experimental COVID vaccines in anyone 18 and younger. AFLDS is seeking immediate injunctive relief in Alabama Federal District Court to stop the use of Emergency Use Authorization (EUA) COVID vaccines — Pfizer/BioNTech, Moderna and Johnson & Johnson (J&J) — for three groups of Americans.
index:
Case 2:21-cv-00702-CLM Document 15 Filed 07/19/21 Page 1 of 67 FILED
2021 Jul-19 PM 01:01
U.S. DISTRICT COURT
N.D. OF ALABAMA
IN THE UNITED STATES DISTRICT COURT FOR THE
NORTHERN DISTRICT OF ALABAMA
AMERICA'S FRONTLINE DOCTORS, et al.,
)
Plaintiffs, )
)
vs. ) Civil Action No.
2:2 1 -cv-00702-CLM
XAVIER BECERRA, Secretary of the U.S. )
Department of Health and Human Services, et al., )
)
Defendants. )
PLAINTIFFS MOTION FOR PRELIMINARY INJUNCTION
Case 2:21-cv-00702-CLM Document 15 Filed 07/19/21 Page 2 of 67
TABLE OF CONTENTS
I. INTRODUCTION................................................................................................................. 3
II. SUMMARY OF FACTS..................................................................................................... 3
A. The Unlawful Vaccine Emergency Use Authorizations............................................... 3
(1) 21 U.S.C. § 360bbb-3(b)(1)(C): There is No Emergency.......................................... 3
(2) § 360bbb-3(c)(1): There is in Fact no Serious or Life-Threatening Disease
or Condition........................................................................................................... 7
(3) § 360bbb-3(c)(2)(A): The Vaccines Do Not Diagnose, Treat or Prevent SARS-CoV-2 or COVID-19 7
(4) § 360bbb-3(c)(2)(B): The Known and Potential Risks of the Vaccines Outweigh their Known and Potential Benefits...................................................................................................... 9
(5) § 360bbb-3(c)(3): There Are Adequate, Approved and Available
Alternatives to the Vaccines......................................................................................20
(6) § 360bbb-3(e)(1)(A)(i) and (ii): Healthcare Professionals and Vaccine Candidates are Not Adequately Informed.................................................................................................................23
(7) § 360bbb-3(e)(1)(A)(iii): Monitoring and Reporting of Adverse Events ................ 32
B. The Under-18 Age Category........................................................................................... 35
C. Those Previously Infected with SARS-COV-2.............................................................. 38
D. Whistleblower Testimony: 45,000 Deaths Caused by the Vaccines............................... 41
III. LAW AND ANALYSIS.................................................................................................... 42
A. Likelihood of Success on the Merits............................................................................... 43
1) Plaintiffs Have Standing........................................................................................... 43
2) Defendants' Actions are Reviewable......................................................................... 44
i. Plaintiffs' Injuries are Within the Zone of Interests......................................... 44
ii. No Statutory Preclusion......................................................................................... 46
iii. The Emergency Declaration and the EUAs are "Final" Agency Action............ 54
iv. Not "Committed to Agency Discretion"............................................................... 56
B. Irreparable Injury.............................................................................................................. 58
C. Balance of Equities (Hardships) and the Public Interest............................................ 64
IV. CONCLUSION ................................................................................................................. 65
CERTIFICATE OF SERVICE .................................................................................... 67